Humana Inc. (NYSE: HUM) has a higher price-to-earnings ratio of 18.37x compared to its average ratio, The 36-month beta value for HUM is at 0.50. Analysts have varying views on the stock, with 5 analysts rating it as a “buy,” 7 rating it as “overweight,” 7 as “hold,” and 0 as “sell.”
The public float for HUM is 120.10M, and currently, shorts hold a 3.14% of that float. The average trading volume for HUM on October 30, 2024 was 2.10M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
HUM) stock’s latest price update
Humana Inc. (NYSE: HUM) has experienced a decline in its stock price by -1.27 compared to its previous closing price of 261.09. However, the company has seen a fall of -1.73% in its stock price over the last five trading days. accesswire.com reported 2024-10-29 that NEW YORK, NY / ACCESSWIRE / October 29, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. (“Humana” or the “Company”) (NYSE:HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
HUM’s Market Performance
HUM’s stock has fallen by -1.73% in the past week, with a monthly drop of -18.62% and a quarterly drop of -28.72%. The volatility ratio for the week is 2.70% while the volatility levels for the last 30 days are 4.83% for Humana Inc.. The simple moving average for the past 20 days is 1.15% for HUM’s stock, with a -24.65% simple moving average for the past 200 days.
Analysts’ Opinion of HUM
Bernstein, on the other hand, stated in their research note that they expect to see HUM reach a price target of $308. The rating they have provided for HUM stocks is “Outperform” according to the report published on October 08th, 2024.
TD Cowen gave a rating of “Hold” to HUM, setting the target price at $261 in the report published on October 07th of the current year.
HUM Trading at -14.86% from the 50-Day Moving Average
After a stumble in the market that brought HUM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -51.10% of loss for the given period.
Volatility was left at 4.83%, however, over the last 30 days, the volatility rate increased by 2.70%, as shares sank -7.76% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -27.03% lower at present.
During the last 5 trading sessions, HUM fell by -1.73%, which changed the moving average for the period of 200-days by -41.24% in comparison to the 20-day moving average, which settled at $254.84. In addition, Humana Inc. saw -43.69% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HUM starting from Mesquita Jorge S., who purchase 545 shares at the price of $367.09 back on Feb 20 ’24. After this action, Mesquita Jorge S. now owns 2,578 shares of Humana Inc., valued at $200,066 using the latest closing price.
Stock Fundamentals for HUM
Current profitability levels for the company are sitting at:
- 0.03 for the present operating margin
- 0.88 for the gross margin
The net margin for Humana Inc. stands at 0.02. The total capital return value is set at 0.1. Equity return is now at value 10.21, with 3.21 for asset returns.
Based on Humana Inc. (HUM), the company’s capital structure generated 0.44 points at debt to capital in total, while cash flow to debt ratio is standing at -0.33. The debt to equity ratio resting at 0.77. The interest coverage ratio of the stock is 5.26.
Currently, EBITDA for the company is 4.73 billion with net debt to EBITDA at 3.23. When we switch over and look at the enterprise to sales, we see a ratio of 0.34. The receivables turnover for the company is 27.39for trailing twelve months and the total asset turnover is 2.24. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.66.
Conclusion
In conclusion, Humana Inc. (HUM) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
